Frequently Asked Questions

Q: WHAT IS THE COLLABORATION BETWEEN UNIVERSITY OF MICHIGAN AND DEERFIELD MANAGEMENT?
A: University of Michigan is collaborating with Deerfield, an investment firm dedicated to advancing healthcare, to accelerate the translation of research in University of Michigan faculty laboratories into clinical therapeutics. Great Lakes Discovery is a Deerfield company that will support University of Michigan’s innovative translational research and leverage Deerfield’s expertise in accelerating state-of-the-art drug development. Great Lakes Discovery will fund projects with the aim of discovering novel therapeutics to cure life-altering diseases.

Through Great Lakes Discovery, Deerfield has committed up to $130 million in initial funding to support promising University of Michigan translational research. This collaboration will provide operational support and may make additional capital investments into spin-off companies that emerge from Great Lakes Discovery projects that show commercial potential.
Q: WHO IS ELIGIBLE TO APPLY?
A: Principal Investigators whose principal employer is University of Michigan or who have a faculty appointment at University of Michigan University and are therefore subject to University of Michigan’s institutional policies are eligible to apply.
Q: HOW CAN I APPLY?
A: To submit an application, please register here to create a Great Lakes Discovery profile or contact U-M Technology Transfer Office by emailing techtransfer@umich.edu
Q: DOES GREAT LAKES DISCOVERY HAVE A THERAPEUTIC AREA OF INTEREST?
A: No – We welcome applications from all therapeutic areas.